Open access peer-reviewed chapter

Prophylactic Medical Treatment of Diabetic Retinopathy

By Akihiro Kakehashi, Ayumi Ota, Fumihiko Toyoda, Nozomi Kinoshita, Hiroko Yamagami, Hiroto Obata, Takafumi Matsumoto, Junichi Tsuji, Yoh Dobashi, Wilfred Y. Fujimoto, Masanobu Kawakami and Yasunori Kanazawa

Submitted: March 14th 2011Reviewed: September 19th 2011Published: February 24th 2012

DOI: 10.5772/29964

Downloaded: 1913

© 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Akihiro Kakehashi, Ayumi Ota, Fumihiko Toyoda, Nozomi Kinoshita, Hiroko Yamagami, Hiroto Obata, Takafumi Matsumoto, Junichi Tsuji, Yoh Dobashi, Wilfred Y. Fujimoto, Masanobu Kawakami and Yasunori Kanazawa (February 24th 2012). Prophylactic Medical Treatment of Diabetic Retinopathy, Diabetic Retinopathy, Mohammad Shamsul Ola, IntechOpen, DOI: 10.5772/29964. Available from:

chapter statistics

1913total chapter downloads

1Crossref citations

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Calcium Dobesilate in Prevention and Treatment of Diabetic Retinopathy

By Oldřich Farsa

Related Book

First chapter

Mechanism of Aqueous Humor Secretion, Its Regulation and Relevance to Glaucoma

By Mohammad Shahidullah, Waleed Hassan Al-Malki and Nicholas A. Delamere

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us